Dow Jones Top Company Headlines at 9 PM ET: Merck No Longer in Talks to Buy Revolution Medicines | The ... The drugmaker had recently been in discussions to acquire RevMed in a deal that could have ...

Philadelphia’s Office of Business Development awarded $450,000 in matching grants to 21 life sciences companies, the first ...

For this list, we screened for S&P 500 companies with a market cap of at least $10 billion and identified stable dividend ...

Biocom CEO says congressional budget action is “encouraging” but great uncertainty still exists in the science world.

Shares of Qiagen have rebounded after three years following a news report that the provider of biotech workflow solutions was evaluating strategic options, which include a potential sale.

The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at ...

XI'AN CITY, SHAANXI PROVINCE, CHINA, January 21, 2026 /EINPresswire.com/ -- The global nootropics and wellness ...

Genentech, a San Francisco-based biotech company, has decided to more than double its investment in a new drug manufacturing facility in North Carolina.

We’re hoping to see more early-stage funding in 2026 to help newer companies get off the ground. The public market, ...

The event launched a “Take Back Your Health” tour after the Health and Human Services Secretary released new national ...

Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.

Pfizer is also making strides in the weight management market. It now owns one of the more promising mid-stage assets in this ...